What is the survival rate for stage 3 non-small cell lung cancer?
According to the American Cancer Society data derived from a database of people diagnosed with lung cancer between 1999 and 2010, the five-year survival rate for stage 3A NSCLC is about 36 percent. For stage 3B cancers the survival rate is about 26 percent. For stage 3C cancers the survival rate is about 1 percent.
How long can you live with lung cancer stage 3?
Summary. Currently, there is no cure for stage 3 lung cancers, but treatment can often help prolong life and relieve symptoms. In some cases, a person with stage 3 lung cancer may survive another 5 years or longer .
What is the life expectancy of someone with non-small cell lung cancer?
5-year relative survival rates for non-small cell lung cancer
| SEER stage | 5-year relative survival rate |
|---|---|
| Localized | 64% |
| Regional | 37% |
| Distant | 8% |
| All SEER stages combined | 26% |
What are the chances of beating stage 3 lung cancer?
More people in the U.S. die of lung cancer than of breast, colon, and prostate cancers combined. About 1 in 3 people diagnosed with stage IIIA lung cancer live for at least 5 years after their diagnosis. For stage IIIB, the average 5-year survival rate is 26%. For stage IIIC, it’s 13%.
Is non-small cell lung cancer the worst?
Small cell cancers vary , depending on the expression of specific genes. Some types are more aggressive than others, but generally, small cell cancer is more aggressive than non-small cell lung cancer.
Does non-small cell lung cancer spread quickly?
Which type of lung cancer spreads the fastest? Small cell lung cancer usually grows and spreads faster than non-small cell lung cancer. Around 70% of small cell lung cancers have already spread at the time of diagnosis.
How serious is non-small cell lung cancer?
For people with localized NSCLC, which means the cancer has not spread outside the lung, the overall 5-year survival rate is 63%. For regional NSCLC, which means the cancer has spread outside of the lung to nearby lymph nodes, the 5-year survival rate is about 35%.